Prospecting for new group A streptococcal vaccine candidates

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 121-125

  McMillan, David J ^a,b,c   Davies, M R ^a,b   Browning, C L ^a,b   Good, M F ^a,b   Sriprakash, K S ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

GAS; Potential vaccine; Superoxide dismutase; Surface proteins

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; EPITOPE; KEYHOLE LIMPET HEMOCYANIN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PEPTIDE; STREPTOCOCCUS VACCINE; SUPEROXIDE DISMUTASE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; BACTERIAL STRAIN; BIOINFORMATICS; CONTROLLED STUDY; DRUG CONJUGATION; DRUG TARGETING; ELUTION; GENOME ANALYSIS; IMMUNITY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGENICITY; MOLECULAR SIZE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; PREDICTION; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SEPARATION TECHNIQUE; STREPTOCOCCUS GROUP A; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; STREPTOCOCCUS PYOGENES;

EID: 3442894444     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470-511.
2. Agarwal BL. Rheumatic heart disease unabated in developing countries. Lancet 1981; ii: 910-1.
3. Stollerman GH. Rheumatic fever. Lancet 1997; 349: 935-42.
4. Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985; 162:583-91.
5. Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 1994; 344: 639-42.
6. Cunningham MW, Hall NK, Krisher KK, Spanier AM. A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol 1986; 136: 293-8.
7. Brandt ER, Hayman WA, Currie B, Carapetis J, Wood Y, Jackson DC, et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 1996; 89:331-7.
8. Dale JB. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine 1999; 17: 193-200.
9. Salvadori LG, Blake MS, McCarty M, Tai JY, Zabriskie JB. Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J Infect Dis 1995; 171:593-600.
10. Ji Y, Carlson B, Kondagunta A, Cleary PP. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococcus. Infect Immun 1997; 65: 2080-7.
11. Kapur V, Maffei JT, Greer RS, Li LL, Adams GJ, Musser JM. Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog 1994; 16: 443-50.
12. Kling DE, Madoff LC, Michel JL. Subcellular fractionation of group B streptococcus. Biotechniques 1999; 27: 24-48.
13. Pancholi V, Fischetti VA. A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med 1992; 176: 415-26.
14. Navarre WW, Schneewind O. Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 1999; 63: 174-229.
15. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 2001; 98: 4658-63.
16. Pruksakorn S, Galbraith A, Houghten RA, Good MF. Conserved T and B cell epitopes on the M protein of group A streptococci: induction of bactericidal antibodies. J Immunol 1992; 149: 2729-35.
17. Cleary P, Retnoningrum D. Group A streptococcal immunoglobulin-binding proteins: adhesins, molecular mimicry or sensory proteins? Trends Microbiol 1994; 2: 131-6.
18. Lynch M, Kuramitsu H. Expression and role of superoxide dismutases (SOD) in pathogenic bacteria. Microbes Infect 2000; 2: 1245-55.
19. Yesilkaya H, Kadioglu A, Gingles N, Alexander JE, Mitchell TJ, Andrew PW. Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae. Infect Immun 2000; 68: 2819-26.
20. Wilks KE, Dunn KL, Farrant JL, Reddin KM, Gorringe AR, Langford PR, et al. Periplasmic superoxide dismutase in meningococcal pathogenicity. Infect Immun 1998; 66: 213-7.
21. Tabatabai LB, Pugh GW Jr. Modulation of immune responses in BALB/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine 1994; 12: 919-24.
22. Vemulapalli R, He Y, Boyle SM, Sriranganathan N, Schurig GG. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun 2000; 68: 3290-6.
23. Hess J, Dietrich G, Gentschev I, Miko D, Goebel W, Kaufmann SH. Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase. Infect Immun 1997; 65: 1286-92.
24. Poyart C, Berche P, Trieu-Cuot P. Characterization of superoxide dismutase genes from Gram-positive bacteria by polymerase chain reaction using degenerate primers. FEMS Microbiol Lett 1995; 131: 41-5.
25. Gibson CM, Caparon MG. Insertional inactivation of Streptococcus pyogenes SOD suggests that prtF is regulated in response to a superoxide signal. J Bacteriol 1996; 178: 4688-95.